Ratios derived from an array of standard haematological indices predict the oncological outcome in colon cancer

Colorectal Disease

Volumn 16, Issue 6, 2014, Pages 442-449

  East, J M ^a   Hogan, J ^b   Samaha, G ^c   Medani, M ^b   Mackerricher, W ^a   Polinkevych, S ^a   Walsh, S R ^a,b   Coffey, J C ^a,b  

^a UNIVERSITY OF LIMERICK   (Ireland)

^b UNIVERSITY HOSPITAL LIMERICK   (Ireland)

^c JOHNS HOPKINS HOSPITAL   (United States)

Author keywords

Cancer; Colorectal; Overall survival; White cell count ratio

Indexed keywords

ADULT; AGED; ARTICLE; CANCER SURGERY; CANCER SURVIVAL; CLASSIFICATION; COLON CANCER; FEMALE; HEMATOLOGICAL PARAMETERS; HUMAN; LEUKOCYTE COUNT; LYMPHOCYTE COUNT; MAJOR CLINICAL STUDY; MALE; NEUTROPHIL LYMPHOCYTE RATIO; OUTCOME ASSESSMENT; OVERALL SURVIVAL; PRIORITY JOURNAL; REGRESSION ANALYSIS; STANDARD; WHITE CELL COUNT LYMPHOCYTE RATIO; BLOOD; CANCER STAGING; CAUSE OF DEATH; COLONIC NEOPLASMS; EPIDEMIOLOGY; FOLLOW UP; INCIDENCE; IRELAND; PREDICTIVE VALUE; PROCEDURES; PROGNOSIS; RETROSPECTIVE STUDY; SURVIVAL RATE; TRENDS; VERY ELDERLY;

TUMOR MARKER;

AGED; AGED, 80 AND OVER; CAUSE OF DEATH; COLONIC NEOPLASMS; FEMALE; FOLLOW-UP STUDIES; HUMANS; INCIDENCE; IRELAND; LEUKOCYTE COUNT; MALE; NEOPLASM STAGING; PREDICTIVE VALUE OF TESTS; PROGNOSIS; RETROSPECTIVE STUDIES; SURVIVAL RATE; TUMOR MARKERS, BIOLOGICAL;

EID: 84900470906     PISSN: 14628910     EISSN: 14631318     Source Type: Journal    
DOI: 10.1111/codi.12561     Document Type: Article

References (27)

1. Ferlay J, Shin H, Bray F, Forman D, Mathers C, Parkin D. GLOBOCAN 2008 v1.2. Cancer Incidence and Mortality Worldwide: IARC CancerBase No.10. 2008. globocan.iarc.fr (accessed January 30, 2013).
2. Coffey J, Wang J, Smith M, Cotter T, Redmond H. Excisional surgery for cancer cure: therapy at a cost. Lancet Oncol 2003; 4: 760-8.
3. Klintrup K, Makinen J, Kauppila S et al. Inflammation and prognosis in colorectal cancer. Eur J Cancer 2005; 41: 2645-54.
4. Roxburgh C, Salmond J, Horgan P, Oien K, McMillan D. Comparison of the prognostic value of inflammation-based pathologic and biochemical criteria in patients undergoing potentially curative resection for colorectal cancer. Ann Surg 2009; 249: 788-93.
5. McMillan D, Crozier J, Canna K, Angerson W, McArdle C. Evaluation of an inflammation-based prognostic score (GPS) in patients undergoing resection for colon and rectal cancer. Int J Colorectal Dis 2007; 22: 881-6.
6. Leitch E, Chakrabarti M, Crozier J et al. Comparison of the prognostic value of selected markers of the systemic inflammatory response in patients with colorectal cancer. Br J Cancer 2007; 97: 1266-70.
7. Ishizuka M, Nagata H, Takagi K, Horie T, Kubota K. Inflammation-Based Prognostic Score is a novel predictor of postoperative outcome in patients with colorectal cancer. Ann Surg 2007; 246: 1047-52.
8. Walsh S, Cook E, Goulder F, Justin T, Kelling N. Neutrophil-lymphocyte ratio as a prognostic factor in colorectal cancer. J Surg Oncol 2005; 91: 181-4.
9. Kishi Y, Kopetz S, Chun Y, Palavecino M, Abdalla E, Vauthey J. Blood neutrophil-to-lymphocyte ratio predicts survival in patients with colorectal liver metastases treated with sytemic chemotherapy. Ann Surg Oncol 2009; 16: 614-22.
10. Ding P, An X, Zhang R et al. Elevated preoperative neutrophil to lymphocyte ratio predicts risk of recurrence following curative resection for stage IIA colon cancer. Int J Colorectal Dis 2010; 25: 1427-33.
11. Murphy J, O'Sullivan G, Lee G et al. The inflammatory response within Dukes' B colorectal cacners: implications for progression of micrometastases and patient survival. Am J Gastroenterol 2000; 95: 3607-15.
12. Chua W, Charles K, Baracos V, Clarke S. Neutrophil/lymphocyte ratio predicts chemotherapy outcomes in patients with advanced colorectal cancer. Br J Cancer 2011; 104: 1288-95.
13. Garzotto M, Beer T, Hudson R et al. Improved detection of prostate cancer using classification and regression tree. J Clin Oncol 2005; 23: 4322-9.
14. Medani M, Kelly N, Burke J et al. An appraisal of lymph node ratio in colon and rectal cancer - not one size fits all. Int J Colorectal Dis 2013; 28: 1377-84.
15. Cook E, Walsh S, Farooq N, Alberts J, Justin T, Keeling N. Post-operative neutrophil-lymphocyte ratio predicts complications following colorectal surgery. Int J Surg 2007; 5: 27-30.
16. Ali AA, McMillan DC, Matalka II, McNicol AM, McArdle CS. Tumor T-lymphocyte subset infiltration and tumor recurrence following curative resection for colorectal cancer. Eur J Surg Oncol 2004; 30: 292-5.
17. Ropponen K, Eskelinen M, Lipponen PK et al. Prognostic value of tumour-infiltrating lymphocytes (TILs) in colorectal cancer. J Pathol 1997; 182: 318-24.
18. Dolcetti R, Viel A, Doglioni C et al. High prevelance of activated intraepithelial cytotoxic T lymphocytes and increased neoplastic cell apoptosis in colorectal carcinomas with microsatellite. Am J Pathol 1999; 154: 1805-13.
19. Strieter R, Burdick M, Mestas J, Comperts B, Keane M, Belperio J. Cancer CXC chemokine networks and tumour angiogenesis. Eur J Cancer 2006; 42: 768-78.
20. Arenberg D, Keane M, DiGiovine B et al. Epithelial-neutrophil activating peptide (ENA-78) is an important angiogenic factor in non-small cell lung cancer. J Clin Invest 1998; 102: 465-72.
21. Kusumanto Y, Dam W, Hospers G, Meijer C, Mulder N. Platelets and granulocytes, in particular the neutrophils, form important compartments for circulating vascular endothelial growth factor. Angiogenesis 2003; 4: 283-7.
22. Halazun K, Aldoori A, Malik H et al. Elevated preoperative neutrophil to lymphocyte ratio predicts survival following hepatic resection for colorectal liver metastases. Eur J Surg Oncol 2009; 34: 55-60.
23. Jass J. Prognostic variables in large bowel cancer. J Clin Pathol 1989; 42: 1006-7.
24. Digiorgio A, Botti C, Tocchi A, Mingazzini P, Flammia M. The influence of tumour lymphocytic infiltration on long term survival of surgically treated colorectal cancer patients. Int Surg 1992; 77: 256-60.
25. Nielsen H, Hansen U, Christensen I, Reimert C, Brunner N, Moesgaard F. Independent prognostic value of eosinophil and mast cell infiltration in colorectal cancer tissue. J Pathol 1999; 189: 487-95.
26. Sharma S, Stolina M, Luo J. Secondary lymphoid tissue chemokine mediates T cell-dependant antitumor responses in vivo. J Immunol 2000; 164: 4558-63.
27. Wang R. The role of MHC class II-restricted tumor antigens and and CD4{thorn} T cells in antitumor immunity. Trends Immunol 2001; 22: 269-76.